Loading organizations...
180 Degree Capital is a publicly traded closed-end management investment company, specializing in undervalued microcapitalization public companies. It employs a constructive activist strategy, acquiring stakes and collaborating with management, driving improvements to unlock value in overlooked public market segments. This distinct approach positions the firm to influence strategic direction and operational efficiency within its portfolio.
Founded in 1981 as Harris & Harris Group by Charles E Harris, the firm initially invested in private technology and life sciences. A pivotal March 2017 shift redefined its thesis, driven by the insight that active engagement in publicly traded small-cap companies offered compelling opportunities. This strategic evolution enabled 180 Degree Capital to leverage its expertise in a new market segment.
The firm attracts public market investors seeking differentiated active management. 180 Degree Capital’s vision demonstrates disciplined, activist involvement transforms underperforming microcap public entities, striving to be a catalyst for full potential and sustainable growth. It aims to generate significant returns by meticulously identifying and nurturing businesses poised for substantial improvement.
Key people at 180 Degree Capital.
180 Degree Capital was founded in 1981 by Douglas W. Jamison (Founder, Chairman and CEO).
180 Degree Capital was founded in 1981 by Douglas W. Jamison (Founder, Chairman and CEO).
Key people at 180 Degree Capital.
180 Degree Capital has 1 tracked investment across 1 company. The latest tracked deal is $31.0M Series A in Magnolia NeuroSciences in August 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 13, 2018 | Magnolia NeuroSciences | $31.0M Series A | — | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, ELI Lilly And Company, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund For NEW York City, Watson Fund, WuXi AppTec |